Similar articles

• Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

  Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group.Moher D, et al.BMJ. 2009 Jul 21;339:b2535. doi: 10.1136/bmj.b2535.BMJ. 2009.PMID:19622551Free PMC article.
• Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

  Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group.Moher D, et al.PLoS Med. 2009 Jul 21;6(7):e1000097. doi: 10.1371/journal.pmed.1000097. Epub 2009 Jul 21.PLoS Med. 2009.PMID:19621072Free PMC article.No abstract available.
• Reprint--preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

  Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group.Moher D, et al.Phys Ther. 2009 Sep;89(9):873-80.Phys Ther. 2009.PMID:19723669No abstract available.
• The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration.

  Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D.Liberati A, et al.BMJ. 2009 Jul 21;339:b2700. doi: 10.1136/bmj.b2700.BMJ. 2009.PMID:19622552Free PMC article.
• The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.

  Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D.Liberati A, et al.J Clin Epidemiol. 2009 Oct;62(10):e1-34. doi: 10.1016/j.jclinepi.2009.06.006. Epub 2009 Jul 23.J Clin Epidemiol. 2009.PMID:19631507

Cited by

• Explainable artificial intelligence in breast cancer detection and risk prediction: A systematic scoping review.

  Ghasemi A, Hashtarkhani S, Schwartz DL, Shaban-Nejad A.Ghasemi A, et al.Cancer Innov. 2024 Jul 3;3(5):e136. doi: 10.1002/cai2.136. eCollection 2024 Oct.Cancer Innov. 2024.PMID:39430216Free PMC article.
• Gamma-knife radiosurgery for jugular foramen schwannomas. A systematic review and meta-analysis.

  Siempis T, Voulgaris S, Alexiou GA.Siempis T, et al.World Neurosurg X. 2024 Sep 26;25:100411. doi: 10.1016/j.wnsx.2024.100411. eCollection 2025 Jan.World Neurosurg X. 2024.PMID:39435265Free PMC article.
• The Potential Diagnostic Accuracy of Circulating MicroRNAs for Leukemia: A Meta-Analysis.

  Zhang WT, Zhang GX, Gao SS.Zhang WT, et al.Technol Cancer Res Treat. 2021 Jan-Dec;20:15330338211011958. doi: 10.1177/15330338211011958.Technol Cancer Res Treat. 2021.PMID:33902358Free PMC article.
• Clinical prediction models of fractional flow reserve: an exploration of the current evidence and appraisal of model performance.

  Zuo W, Zhang R, Yang M, Ji Z, He Y, Su Y, Qu Y, Tao Z, Ma G.Zuo W, et al.Quant Imaging Med Surg. 2021 Jun;11(6):2642-2657. doi: 10.21037/qims-20-1274.Quant Imaging Med Surg. 2021.PMID:34079730Free PMC article.
• Surgical Resection of a Recurrent Hepatocellular Carcinoma with Portal Vein Thrombosis: Is It a Good Treatment Option? A Case Report and Systematic Review of the Literature.

  Sena G, Paglione D, Gallo G, Goglia M, Osso M, Nardo B.Sena G, et al.J Clin Med. 2022 Sep 7;11(18):5287. doi: 10.3390/jcm11185287.J Clin Med. 2022.PMID:36142934Free PMC article.Review.

Publication types

• Guideline
• Research Support, Non-U.S. Gov't

MeSH terms

• Evidence-Based Practice / standards
• Humans
• Meta-Analysis as Topic*
• Periodicals as Topic / standards
• Publication Bias
• Publishing / standards*
• Quality Control
• Review Literature as Topic*
• Terminology as Topic*

Related information

• Cited in Books

Grants and funding

LinkOut - more resources

• Full Text Sources

  • Atypon
  • CORE
  • Ovid Technologies, Inc.

• Other Literature Sources

  • H1 Connect - Access expert opinions and insights on biomedical research.